ProMIS Neurosciences Inc - Company Profile

Powered by

All the sales intelligence you need on ProMIS Neurosciences Inc in one solution.

$ $295
Register your interest Learn more
  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how ProMIS Neurosciences Inc fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with ProMIS Neurosciences Inc.

Back to companies

ProMIS Neurosciences Inc: Patents

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

View up-to-date information on ProMIS Neurosciences Inc patents, including inventor and filing insights.

Patent Trends

Publication Identifier Document Type Title Classification-CPC Publication Date
US11779629B2 Grant Compositions comprising cyclic peptides derived from an a-beta peptide C12N5/10; C12N5/16; A61K2039/505; A61K2039/55505; A61K2039/6081; A61K2300/00; A61K38/00; A61K38/05; A61K38/07; A61K38/08; A61K38/12; A61K39/00; A61K39/385; A61K39/39; A61K39/395; A61K39/39533; A61K39/3955; A61K45/05; A61K45/06; A61K47/643; A61K47/646; A61K47/6803; A61K47/6921; A61K49/1818; A61K49/1866; A61K51/088; A61K51/10; A61K51/1018; A61L27/227; A61L27/34; A61L29/085; A61L29/16; A61L31/10; A61L31/16; A61P25/28; C07K14/435; C07K14/4711; C07K16/18; C07K2317/20; C07K2317/24; C07K2317/30; C07K2317/33; C07K2317/34; C07K2317/524; C07K2317/526; C07K2317/54; C07K2317/55; C07K2317/56; C07K2317/565; C07K2317/569; C07K2317/624; C07K2317/626; C07K2317/70; C07K2317/76; C07K2317/92; C07K2317/94; C07K2319/00; C07K5/0808; C07K5/081; C07K5/0812; C07K5/0815; C07K5/0819; C07K5/0821; C07K5/101; C07K5/1021; C07K5/1024; C07K7/06; C07K7/08; C07K7/64; G01N2333/4709; G01N2800/28; G01N2800/2821; G01N2800/387; G01N33/5058; G01N33/6896 October 10, 2023
CN116333108A Application Antibodies to amyloid beta C12N5/16; A61K2039/505; A61K38/1716; A61K39/0007; A61K47/6843; A61K49/0008; A61K51/1018; A61P25/28; C07K16/18; C07K2317/24; C07K2317/33; C07K2317/34; C07K2317/55; C07K2317/565; C07K2317/76; C07K2317/92; G01N2333/4709; G01N2800/2821; G01N33/60; G01N33/6854; G01N33/6896 June 27, 2023
EP3976793A4 Search Report Konformationsspezifische epitope in tau, antikörper dagegen und verfahren im zusammenhang damit C12N5/163; A61K2039/55505; A61K39/0005; A61K39/385; A61K39/39; A61K47/643; A61K47/646; A61P25/28; C07K14/4711; C07K16/18; C07K2317/32; C07K2317/34; C07K2317/56; C07K2317/565; C07K2317/76; C07K5/0827; C07K5/1008; C07K5/101; C07K5/1019; C07K5/12; C07K7/06; G01N2333/4709; G01N2800/2821; G01N33/6896 June 21, 2023
JP2023086132A Application Antibodies to amyloid beta A61K2039/505; A61P25/28; C07K16/18; C07K2317/24; C07K2317/92; G01N2333/4709; G01N33/6896 June 21, 2023
US20230141177A1 Application Antibodies to misfolded amyloid beta A61K2039/505; A61K47/6843; A61P25/28; C07K16/18; C07K2317/24; C07K2317/32; C07K2317/33; C07K2317/34; C07K2317/522; C07K2317/524; C07K2317/55; C07K2317/565; C07K2317/622; C07K2317/92; G01N2333/4709; G01N33/532; G01N33/6896 May 11, 2023
Gain a 360-degree view of and make more informed decisions for your business Gain a 360-degree view of and make more informed decisions for your business Learn more

Top Inventors by Filings (Count by publication)

Name Count
Identify the top inventors associated with your target company when you unlock full profile Identify the top inventors associated with your target company when you unlock full profile Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer